Skip to main content

ATORX · Alligator Bioscience AB · Investor Relations

0.0173 SEK +0.0001 (+0.58%) At close · Oct 7
Market Cap
62.09M SEK
Shares
3.57B

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-10-22 00:00 UTC Interim report Q3 2026 Results publication
2027-02-11 00:00 UTC Year-end report 2026 Results publication

Past events

Date Event Type
2026-08-26 Interim report H1 2026 Results publication
2026-05-06 Annual General Meeting Shareholder meeting
2026-05-05 Interim report Q1 2026 Results publication
2026-03-06 CSO Peter Ellmark presents at the 10th Zurich Immuno-Oncology Symposium Event
2026-02-12 Year-end report 2025 Results publication
2026-01-31 Deadline for Alligator Bioscience’s shareholders to submit resolutions to be considered by the Annual General Meeting Shareholder meeting
2025-11-12 CEO Søren Bregenholt presents at BioStock’s Life Science Summit 2025 Event
2025-10-23 Alligator’s Q2 2025 call Earnings call
2025-09-23 CEO Søren Bregenholt presents at BioStock’s Investing in Life Science event Event
2025-08-19 R&D event Event
2025-07-10 Alligator’s Q2 2025 call Earnings call
2025-06-16 CEO Søren Bregenholt presents at BIO International Convention Event
2025-05-21 CEO Søren Bregenholt presents at Biostock – The Global Forum 2025 Event
2025-05-14 CEO Søren Bregenholt presents at Vator Securities Life Science Summit 2025 Event
2025-04-26 Alligator’s Q1 2025 call Earnings call
2025-04-02 CEO Søren Bregenholt presents at Van Lanschot Kempen Life Sciences Conference i Amsterdam Conference
2024-06-11 CEO Søren Bregenholt presents at the event Aktiedagarna in Stockholm, hosted by Swedish Aktiespararna Event
2024-04-02 Alligator Bioscience on the importance of prolonging life Event
2024-03-25 Investor pitch at Biostock Event
2024-03-20 CEO Søren Bregenholt presents at Økonomisk Ugebrev Lifescience Conference in Copenhagen Conference
2024-02-20 Interview with CMO Sumeet Ambarkhane on the coming plans for mitazalimab Event
2024-02-16 CEO Søren Bregenholt comments on the restructuring plan at Biostock Event
2024-02-09 Alligator Bioscience Year-end report January – December 2023 with CEO Søren Bregenholt, CFO Marie Svensson and CMO Sumeet Ambarkhane Results publication
2024-01-29 KOL-event on the OPTIMIZE-1 top-line data featuring Professor Zev Wainberg at UCLA Health, CEO Søren Bregenholt and CMO Sumeet Ambarkhane Event
2024-01-29 CEO Søren Bregenholt interviewed by Redeye’s Richard Ramanius on the OPTIMIZE-1 top-line readout Event

Source: https://alligatorbioscience.se/en/investors/